On Sept. 19, the Food and Drug Administration (FDA) approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Read more
FDA approves first drug for treating Duchenne muscular dystrophy
Share